StockData
IGC Pharma, Inc. logo

IGC Pharma, Inc. (IGC) stock

IGCNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 2/309% above fair value
$0.18−0.01 (-4.61%)

Close on Nov 13, 2026Market cap $18.20MP/E –Yield –

IGC Pharma price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

IGC Pharma's price to book ratio was 3.3× on Nov 11, 2026, against 3.6× a year earlier. Over the last 5 years it ranged from 0.8× to 6.0×, with a median of 3.2×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.3×+0.1
2025Dec 31, 20253.2×−0.3
2024Dec 31, 20243.5×+2.2
2023Dec 29, 20231.3×+0.4
2022Dec 30, 20220.8×−0.8
2021Dec 31, 20211.6×−1.1
2020Dec 31, 20202.7×+1.9
2019Dec 31, 20190.8×+0.1
2018Dec 31, 20180.7×+0.7
2017Dec 29, 20170.0×+0.0
2016Dec 30, 20160.0×+0.0
2015Dec 31, 20150.0×−0.0
2014Dec 31, 20140.0×−0.0
2013Dec 31, 20130.0×−0.0
2012Dec 31, 20120.0×–

More IGC Pharma figures

See a number that looks wrong?